We did not observe significant differences in BM percentage of CD3+CD4+IL-4+ (4.0% vs 3.1%) and CD3+CD4+IFN-γ+ (12.9% vs 7.65%) between RA and OA patients (Fig. 2d, e). The gene discussed is CD4; the disease is rheumatoid arthritis.